BASIC2BEMISAL | NIFTY I BANKNIFTY | BTST 📶☺️👍

Stocks under F&O ban on NSE Canara Bank, Granules India, Delta Corp, Hindustan Copper, Indiabulls Housing Finance, Manappuram Finance.

Stocks under F&O ban on NSE Canara Bank, Granules India, Delta Corp, Hindustan Copper, Indiabulls Housing Finance, Manappuram Finance.

Stocks in the news State Bank of India: The country's largest lender has raised Rs 10,000 crore at a coupon rate of 7.49 percent through its fourth infrastructure bond issuance. The investors were across provident funds, pension funds, insurance companies, mutual funds, corporates, etc. The proceeds of bonds will be utilised to enhance long-term resources for funding infrastructure and the affordable housing segment. JSW Steel: The company has executed the termination agreement with National Steel Holding (NSHL) for the termination of the joint venture agreement for establishing scrap shredding facilities in India and the Securities Purchase Agreement with NSHL to purchase NSHL's 50 percent stake held in NSL Green Recycling. Post the transaction, NSL will become a wholly owned subsidiary of JSW Steel. Shree Renuka Sugars: The sugar company has received board approval for entering into binding agreements to acquire Anamika Sugar Mills for Rs 235.5 crore, to establish a presence in Uttar Pradesh. Further, it will also infuse up to Rs 110 crore in Anamika through equity shares for the redemption of 100 percent of outstanding cumulative redeemable preference shares (CRPS) issued by Anamika in favour of SICPA India. Vaibhav Global: Subsidiary Shop TJC Ltd (UK) has successfully executed an Asset Sale Agreement to acquire assets of Ideal World, a teleshopping brand in the United Kingdom. With this agreement, Shop TJC will acquire Ideal World's IP rights, broadcasting rights, studio equipment along with other intangible assets. The transaction will be funded through internal accruals. Suzlon Energy: State-owned REC has withdrawn its nominee, Ajay Mathur, from the board of Suzlon Energy as the financial assistance granted by the REC-led consortium in terms of the rupee term loan agreement has been paid in full. Ajay Mathur has ceased to be the Nominee Director of Suzlon with effect from September 21. Reliance Industries: Subsidiary Reliance Retail Ventures has received the subscription amount of Rs 2,069.50 crore from Alyssum Asia Holdings II Pte Ltd (KKR) and allotted 1,71,58,752 equity shares to KKR. Delta Corp: The casino chain has received an intimation from the Directorate General of GST Intelligence, Hyderabad, for payment of an alleged tax liability of Rs 11,139.61 crore along with interest and penalty from July 2017 to March 2022. Further, if the company fails to do so, the show cause notice will be issued to the company. The amount claimed in the DG Notice is based on the gross bet value of all games played at the casinos during the relevant period.

Good time to add Gujarat Gas , Ambuja, acc, wipro, Pel , ubl, usl

Cash Call:* J&K Bank Buy at 108.8 TGT 115.0 Stoploss 105.0

Buy BANDHANBNK @ 249-252 with a Target of 260  in 6 days. Stop Loss 245 -

BAN Stocks under F&O NSE Balrampur Chini Mills, BHEL, Chambal Fertilizers & Chemicals, Delta Corp, Hindustan Copper, Indiabulls Housing Finance, Manappuram Finance, Punjab National Bank Zee Entertainment

Stocks in the news EMS: The sewerage solutions company will list shares on the BSE and NSE on September 21. The issue price has been fixed at Rs 221 per share. SJVN: The government is going to sell up to 9,66,72,962 equity shares or 2.46 percent stake in the hydroelectric power generation company on September 21 and 22, with an option to additionally sell 9,66,72,961 equity shares or 2.46 percent stake. OFS opens for non-retail investors on September 21 and retail investors on September 22. The floor price of the offer will be Rs 69 per share. Biocon: Subsidiary Biocon Biologics has received approval from the European Commission for marketing authorisation in the European Union (EU) for YESAFILI, a biosimilar of Aflibercept. YESAFILI, an ophthalmology product, is used for the treatment of neovascular (wet AMD) age-related macular degeneration, and visual impairment due to macular oedema secondary to retinal vein occlusion. Cipla: After the inspection, InvaGen's manufacturing facility in Central Islip, New York has received 5 inspectional observations in Form 483, from US FDA. There are no repeat or data integrity observations. The US FDA inspected the said facility of subsidiary InvaGen Pharmaceuticals Inc during September 11-19. The inspection was a routine current good manufacturing practices inspection and a pre-approval inspection (PAI) for a site transfer product within InvaGen. Apollo Tyres: Bias and OTR tyre production at the company's manufacturing facility in Limda, Gujarat has been stopped due to certain concerns amongst shop floor employees relating to the renewal of the long-term settlement agreement. The company is in discussions and negotiations with the labour union representatives to address their concerns and find an amicable resolution. There is no material impact on the operations at this stage. Infosys: The country's second-largest IT services provider and Nasdaq-listed NVIDIA have expanded their strategic collaboration with the aim to help enterprises worldwide, drive productivity gains with generative AI applications and solutions. Infosys will train 50,000 employees on NVIDIA AI technology. Zydus Lifesciences: The pharma company has received final approval from the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Gel USP, 1 percent which is used to treat acne. The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad. The drug had annual sales of $37 million in the United States as per IQVIA MAT July 2023.